A Phase II, Double Blind, Randomised, Placebo and Active Comparator Controlled Study to Assess the Safety and Efficacy of Three Doses of Dysport RU (20 U, 50 U, and 75 U) Administered as a Single Treatment Cycle to Improve the Appearance of Moderate to Severe Glabellar Lines
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008358/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective is to assess the dose response versus placebo of a single treatment of
Dysport RU (Dysport RU, Ready to Use, for injection), for the improvement in appearance of
moderate to severe glabellar lines at maximum frown.
提供机构：
Vivli
创建时间：
2022-08-16
